Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
It's a different product entirely. I don't really understand your post if I'm honest.
That's two months ago - cash is being spent on Akatara all the time.
I think that net cash position is wrong but rest applies.
Clueless idiots - not a clue.
Good points - unless there is something untoward going on in the background then yes it makes no sense but in times of difficult markets small volumes have a geared effect. As you say that can be to the upside as well as downside!
More press which is great but there are few ways of looking at it. 1) Science is OK but not good enough yet to RNS so press and more publicity needed to try and get funding for next stages 2) Everything is going really but want to release great news once confirmed and more evidence. Hard to know which it is closer to or something completely different?
Got a bit of a pump on Voxmarkets again.
Yes, more exposure can't be a bad thing. Hopefully more commercial contracts being worked through.
Sounds like we are there or thereabouts - https://twitter.com/Attaqa0/status/1653837403142889472
Iraq is preparing to resume exporting oil from the fields of the Kurdistan region after the conclusion of contracts with importing companies, and the examination of the export pipeline by the Turkish company BOTAS (Statement of the Iraqi Oil Ministry)
Finally updated investor meet Q&A!
https://www.investormeetcompany.com/investor/meeting/investor-update-29
That was back in October - so what?
A lot has happened since then macro wise! Not forgetting the point on financing and how much harder it is now.
Scientists aren't particularly good with Corporate Finance. That's the challenge.
It's not an issue right now the challenge of financing becoming an issue is there.
It clearly isn't - the share price reflects it.
Recent weakness is probably a reflection of funding runway and what Scancell do next - equity raise? Back to select investors or try to tap debt markets? Lots of options but time is ticking.
I'm more inclined to the idea that it's much more likely mathematically NOT to be Modi given the number of other trials occurring. In fact it's highly unlikely it is Modi based on the evidence.
You're making yourself look very silly on this forum constantly spewing out nonsense.
No, the others have less direct interest in Kurdistan and Genel for example has a lot more cash.
Where's the statement from Iraq or Turkey?
I think you are trying to scare holders into selling tomorrow.